Private: Gallery Post #1

22

Feb2019
CADTH is launching a new Patient and Community Advisory Committee After talks with patient groups this past fall, CADTH is creating a 12-person advisory committee to discuss the experiences of patients and family caregivers in Canada. They invite nominations for those with extensive experience as a patient or family caregiver in ... Read More

15

Feb2019
The Office of the pan-Canadian Pharmaceutical Alliance (pCPA) assesses brand name drug products for public funding either collectively or individually at the provincial and territorial levels. Each month the pCPA issues an update on the previous month’s negotiation activity. A file is complete once a Letter of Intent (LOI) is ... Read More

11

Feb2019
In keeping with our continuing efforts to support transparency and share input submissions for public policy consultations, PDCI is hosting responses to a recent CADTH survey that was conducted on behalf of the Provincial/Territorial (P/T) Expensive Drugs for Rare Disease Working Group (EDRD WG). The EDRD WG sought public feedback ... Read More

07

Feb2019
On February 6, 2019, CADTH announced a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer Parallel Scientific Advice to pharmaceutical companies. Participating pharmaceutical companies will receive advice simultaneously from CADTH and NICE to facilitate evidence generation for the Canadian and English markets. This new opportunity ... Read More

04

Feb2019
Observations on National Pharmacare from John-Paul Dowson, PDCI’s Director of Reimbursement Strategy.

17

Jan2019
The Office of the pan-Canadian Pharmaceutical Alliance (pCPA) assesses brand name drug products for public funding either collectively or individually at the provincial and territorial levels. Each month the pCPA issues an update on the previous month’s negotiation activity. A file is complete once a Letter of Intent (LOI) is ... Read More

20

Dec2018
New updates from pCODR are as follows: Webinar on Clinician Input and Feedback Seminar CADTH is hosting a webinar in collaboration with Innovation Medicines Canada (IMC) on January 22nd, 12:00 pm to 1:00 pm EST, to provide detailed information about this process and new tools being offered for clinicians. This webinar ... Read More

12

Nov2018
INESSS has launched a modernized website that is more user-friendly and provides greater transparency. Some of the highlighted new features includes: Enhanced search engine that allows broader searches throughout the full website and that offers additional Advance Search filters. New Social Services, Drugs and Health Services sections which provide new ... Read More

01

Oct2018
Did you or your organization submit written comments to the recent national pharmacare consultation? If so, PDCI has volunteered to accumulate & share submissions from all stakeholders on a centrally located webpage available here. If you would like your voice added to this important policy discussion, please send ... Read More

28

Aug2018
***Participation Requested*** Sharing Responses to the National Pharmacare Public Consultation Announced in the 2018 federal budget and chaired by former Ontario Health Minister Eric Hoskins, the Advisory Council on the Implementation of National Pharmacare is currently engaging in a national dialogue on how the federal government could implement ... Read More